๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Epidermolysis bullosa simplex (EBS) is a rare genetic skin disease characte...
Status
Terminated
Location
Phoenix Childrens Hospital
Start Date
2017-06-01
Trial ID
NCT03154333
Treatments Being Tested
Bullous pemphigoid (BP) is a chronic, inflammatory, subepidermal, autoimmun...
Status
Terminated
Location
National Taiwan University Hospital
Start Date
2017-09-05
Trial ID
NCT03286582
Treatments Being Tested
The goal of this clinical trial is to evaluate the safety and effectiveness...
Status
Not Yet Recruiting
Location
Kasr Al-Ainy Psoriasis Unit
Start Date
2026-02-01
Trial ID
NCT07352306
Single center, randomized, controlled, evaluator blinded, within-subject st...
Status
Completed
Location
TKL Research
Start Date
2018-01-15
Trial ID
NCT03472547
Treatments Being Tested
The purpose of this study is to evaluate the pain relief effect of Co-admin...
Status
Unknown
Location
Seoul ST. Mary's Hospital
Start Date
2018-01-25
Trial ID
NCT03404479
The purpose of this study is to evaluate clinical effectiveness of diacerei...
Status
Completed
Location
Kuljinder Singh
Start Date
2007-01
Trial ID
NCT01120015
Treatments Being Tested
The purpose of this study is to compare pain scores, WOMAC total and subsco...
Status
Completed
Location
Department of Orthopaedics, Faculty of Medicine Ramathibodi Hospital, Bangkok, Mahidol University
Start Date
2013-07
Trial ID
NCT01906801
Treatments Being Tested
To evaluate the efficacy of Diacerein 100 mg daily versus placebo in reduci...
Status
Completed
Location
Juree Rawdmanee
Start Date
2010-10
Trial ID
NCT01264211
Inherited epidermolysis bullosa (EB) is a genetic skin disorder characteriz...
Status
Completed
Location
Mackay Memorial Hospital
Start Date
2018-10-20
Trial ID
NCT03468322
This is a 24-week randomized placebo-controlled study to investigate the ef...
Status
Completed
Location
Catalina Research Institute, LLC
Start Date
2011-01
Trial ID
NCT01276106
Treatments Being Tested